Ob Drugs Exam 1

Front 1

DRUG CLASS- antidote, tocolytic, fat soluble vitamins

Back 1

MAG SULFATE

Front 2

OB USE- PREVENTION AND TREAMENT OF hypoprothrombonemia
prevention of hemorraghic disease of the newborn

Back 2

MAG SULFATE

Front 3

Dosage and route of administration- PO,SUBQ, IM, IV,
2.5-10MG, 1-2 MG INFANTS

Back 3

mag sulfate

Front 4

contrainidcations- hypersensitivity, use cautiously in impaired liver function

Back 4

mag sulfate

Front 5

SIDE EFFECTS- Muscle weakness.
Lack of energy and drowsiness.
Decreased effort in breathing (respiratory depression).
Low blood pressure and fast pulse.
These side effects can decrease over the duration of treatment and go away when the medication is stopped.

Back 5

MAG SULFATE

Front 6

Nursing implications- monitor for frank and occult bleeding, apply pressure to all venipuncture sites for at least 5min, PT should be monitored prior to threapy and throughout to monitor.
Parenteral rout e preferredbc of severe sensitivity, antidote for warfarin but not heparin
IF IV administration is unavoidable, push at 1MG/MIN

Back 6

MAG SULFATE

Front 7

medications used to suppress premature labor

Back 7

Tocolytics

Front 8

β2-adrenergic receptor agonist, used as a fast-acting bronchodilator (often used as a short-term asthma treatment) and as a tocolytic to delay premature labour.

Back 8

terbutaline

Front 9

Maternal - tachycardia, nervousness, tremors, headache, hyperglycemia, hypokalemia, and rarely, pulmonary edema.[1]
Fetal - tachycardia and hypoglycemia

Back 9

terbutaline side effects

Front 10

orally (by mouth), by injection under the skin (also known as "sub-Q"-short for subcutaneous), or intravenously (through an IV). The common oral dosage ranges from 10 to 30 mg, with a maximum daily dose of about 40 mg. The subcutaneous dose is 0.25 mg every 20 to 60 minutes until a woman's contractions have subsided.

Back 10

terbutaline dosage and route of administration

Front 11

Since most of the uterus is made up of smooth muscle, the uterus will relax in response to a drug that contains substances like epinephrine.

Back 11

terbutaline

Front 12

heart disease, hyperthyroidism, and poorly controlled diabetes.

Back 12

contraindications

Front 13

It works by causing the uterus to contract. It is used to increase the strength of contractions of the uterus. It can be used during childbirth to speed delivery or after childbirth to control bleeding. It is also used clear the uterus after an incomplete abortion or miscarriage.Oxytocin (pronounced /ˌɒksɨˈtoʊsɪn/) is a mammalian hormone that also acts as a neurotransmitter in the brain.

Back 13

pitocin

Front 14

dinoprostone, prostaglandin E2
medicines for blood pressure
medicines used for sleep during surgery
other medicines to contract the uterus, ephedra

Back 14

pitocin drug interactions

Front 15

allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
breathing problems
excessive or continuing vaginal bleeding
fast, irregular heartbeat
feeling faint or lightheaded, falls
high blood pressure
seizures
unusual bleeding or bruising
unusual swelling, sudden weight gain

Back 15

side effects that require immediate attention for pitocin

Front 16

headache
nausea and vomiting

Back 16

pitocin side effects

Front 17

ntravenous infusion (drip method) is the only acceptable method of parenteral administration of Pitocin for the induction or stimulation of labor. Accurate control of the rate of infusion is essential and is best accomplished by an infusion pump. It is convenient to piggyback the Pitocin infusion on a physiologic electrolyte solution, permitting the Pitocin infusion to be stopped abruptly without interrupting the electrolyte infusion.

Back 17

route of administration for pitocin

Front 18

The initial dose should be 0.5-1 mU/min (equal to 3-6 mL of the dilute oxytocin solution per hour). At 30-60 minute intervals the dose should be gradually increased in increments of 1-2 mU/min until the desired contraction pattern has been established. Once the desired frequency of contractions has been reached and labor has progressed to 5-6 cm dilation, the dose may be reduced by similar increments.

Back 18

pitocin dosage

Front 19

Monitoring
a. Electronically monitor the uterine activity and the fetal heart rate throughout the infusion of Pitocin. Attention should be given to tonus, amplitude and frequency of contractions, and to the fetal heart rate in relation to uterine contractions. If uterine contractions become too powerful, the infusion can be abruptly stopped, and oxytocic stimulation of the uterine musculature will soon wane (see PRECAUTIONS section).

b. Discontinue the infusion of Pitocin immediately in the event of uterine hyperactivity and/or fetal distress. Administer oxygen to the mother, who preferably should be put in a lateral position. The condition of mother and fetus should immediately be evaluated by the responsible physician and appropriate steps taken.

Back 19

Pitocin monitoring

Front 20

Intravenous infusion (drip method). If the patient has an intravenous infusion running, 10 to 40 units of oxytocin may be added to the bottle, depending on the amount of electrolyte or dextrose solution remaining (maximum 40 units to 1000 mL). Adjust the infusion rate to sustain uterine contraction and control uterine atony.
Intramuscular administration, (One mL) Ten (10) units of Pitocin can be given after the delivery of the placenta.

Back 20

control postpartum bleeding with pitocin

Front 21

fetal distress, hydramnios, partial placenta previa, prematurity, borderline cephalopelvic disproportion, and any condition in which there is a predisposition for uterine rupture, such as previous major surgery on the cervix or uterus including cesarean section, overdistention of the uterus, grand multiparity, or past history of uterine sepsis or of traumatic delivery.

Back 21

pitocin contraindications

Front 22

Sterile Solution, an oxytocic,is indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion.treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management. Prior treatment should include the use of intravenously administered oxytocin, manipulative techniques such as uterine massage and, unless contraindicated, intramuscular ergot preparations. Studies have shown that in such cases, use resulted in satisfactory control of hemorrhage

Back 22

Hemabate indications & drug class

Front 23

An initial dose of 250 micrograms of HEMABATE Sterile Solution (1 mL of HEMABATE) is to be given deep, intramuscularly.The total dose of HEMABATE should not exceed 2 milligrams (8 doses).

Back 23

Hemabate dosage and route

Front 24

must be refrigerated at 2° to 8° C (36° to 46° F).Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Back 24

Hemabate administration

Front 25

are generally transient and reversible when therapy ends. The most frequent adverse reactions observed are related to its contractile effect on smooth muscle.vomiting and diarrhea, approximately one-third had nausea, one-eighth had a temperature increase greater than 2° F, and one-fourteenth experienced flushing.

Back 25

Hemabate side effects

Front 26

HEMABATE may augment the activity of other oxytocic agents. Concomitant use with other oxytocic agents is not recommended.

Back 26

hemabate drug interactions